1.
The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy . Ann Med Res . 2021;26(10):2098-2104. Accessed April 3, 2025. http://annalsmedres.org/index.php/aomr/article/view/1820